Gain Therapeutics, Inc. - GANX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$26.31M
QoQ value delta ($000)
+$18.64M (+242.8%)
Implied price effect (QoQ)
+81.88%
Shares
Total shares
8,187,901
QoQ shares delta
+3,843,648 (+88.48%)
Total shares held by funds (by quarter)

Market chart (GANX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 4 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
MARSHALL WACE, LLP 5,352 1,662,293 0.0%
Potomac Capital Management, Inc. 3,252 1,010,000 2.61%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 2,347 728,949 0.0%
JONES FINANCIAL COMPANIES LLLP 2,261 702,213 0.0%
VANGUARD GROUP INC 1,835 569,901 0.0%
Cambridge Investment Research Advisors, Inc. 1,831 568,645 0.0%
DME Capital Management, LP 1,822 566,130 0.06%
GEODE CAPITAL MANAGEMENT, LLC 1,282 397,942 0.0%
JANE STREET GROUP, LLC 780 242,328 0.0%
BlackRock, Inc. 674 209,579 0.0%
Cresset Asset Management, LLC 515 160,000 0.0%
STATE STREET CORP 507 157,537 0.0%
MORGAN STANLEY 475 147,591 0.0%
LPL Financial LLC 343 106,550 0.0%
NORTHERN TRUST CORP 328 102,001 0.0%
UBS Group AG 261 81,121 0.0%
Focus Partners Wealth 250 77,855 0.0%
CITADEL ADVISORS LLC 249 77,500 0.0%
HRT FINANCIAL LP 179 55,679 0.0%
GROUP ONE TRADING LLC 174 54,159 0.0%
SIMPLEX TRADING, LLC 154 47,946 0.0%
BENEDICT FINANCIAL ADVISORS INC 122 38,000 0.03%
OMERS ADMINISTRATION Corp 120 37,300 0.0%
PRELUDE CAPITAL MANAGEMENT, LLC 115 35,820 0.01%
GOLDMAN SACHS GROUP INC 104 32,494 0.0%